These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8173163)
1. Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis. Sobol H; Mazoyer S; Smith SA; Lyonnet D; Bignon YJ; Narod SA; Ardoin A; Biron P; Bobin JY; Bremond A Bull Cancer; 1993 Feb; 80(2):121-34. PubMed ID: 8173163 [TBL] [Abstract][Full Text] [Related]
2. [Genetics and cancer of the breast]. Sobol H; Bignon YJ; Eisinger F; Birnbaum D; Fervers B Ann Chir; 1994; 48(4):303-8. PubMed ID: 8085754 [TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations. Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
5. [Hereditary predisposition for cancer of the breast and the ovary]. Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923 [TBL] [Abstract][Full Text] [Related]
6. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Smith SA; Easton DF; Evans DG; Ponder BA Nat Genet; 1992 Oct; 2(2):128-31. PubMed ID: 1303261 [TBL] [Abstract][Full Text] [Related]
7. Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Torchard D; Blanchet-Bardon C; Serova O; Langbein L; Narod S; Janin N; Goguel AF; Bernheim A; Franke WW; Lenoir GM Nat Genet; 1994 Jan; 6(1):106-10. PubMed ID: 7511021 [TBL] [Abstract][Full Text] [Related]
8. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013 [TBL] [Abstract][Full Text] [Related]
9. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282 [TBL] [Abstract][Full Text] [Related]
10. Analysis of breast cancer pedigrees using affected sibship methods. Barrett JH; Rigby AS Genet Epidemiol; 1995; 12(6):847-51. PubMed ID: 8788020 [TBL] [Abstract][Full Text] [Related]
11. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis. Güran S; Ozet A; Dede M; Gille JJ; Yenen MC Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273 [TBL] [Abstract][Full Text] [Related]
12. The search for the familial breast/ovarian cancer gene. Black DM; Solomon E Trends Genet; 1993 Jan; 9(1):22-6. PubMed ID: 8434413 [TBL] [Abstract][Full Text] [Related]
13. A 45-year follow-up of kindred 107 and the search for BRCA2. Goldgar DE; Neuhausen SL; Steele L; Fields P; Ward JH; Tran T; Ngyuen K; Stratton MR; Easton DF J Natl Cancer Inst Monogr; 1995; (17):15-9. PubMed ID: 8573446 [TBL] [Abstract][Full Text] [Related]
14. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method]. Byrski T Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838 [TBL] [Abstract][Full Text] [Related]
15. A novel p53 germline alteration identified in a late onset breast cancer kindred. Sun XF; Johannsson O; Håkansson S; Sellberg G; Nordenskjöld B; Olsson H; Borg A Oncogene; 1996 Jul; 13(2):407-11. PubMed ID: 8710380 [TBL] [Abstract][Full Text] [Related]
16. [Familial neoplastic syndromes of the ovary. A family study]. Di Vagno G; Nacci G; Cormio G; Loverro G Minerva Ginecol; 1994 Oct; 46(10):571-4. PubMed ID: 7838415 [TBL] [Abstract][Full Text] [Related]
17. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer. Cortessis V; Ingles S; Millikan R; Diep A; Gatti RA; Richardson L; Thompson WD; Paganini-Hill A; Sparkes RS; Haile RW Cancer Res; 1993 Nov; 53(21):5083-6. PubMed ID: 8221639 [TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252 [TBL] [Abstract][Full Text] [Related]
19. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene. Hamann U; Brauch H; Garvin AM; Bastert G; Scott RJ Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962 [TBL] [Abstract][Full Text] [Related]
20. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]